Psilocybin
Safe Supply Streaming Begins Trading on the CSE
Safe Supply went public on the CSE this week, the first publicly-traded company focused on the safe supply ecosystem.
The post Safe Supply Streaming Begins…
With decriminalization efforts moving forward in many jurisdictions, and with clinical trials nearing government approval, ensuring safe and reliable supply of psychoactive compounds will be a crucial part of the industry’s future.
Enter Safe Supply Streaming. The company is investing in and incubating companies at the forefront of drug policy reform. From developing facilities to analyze, manufacture and distribute psychoactive compounds, to investing in research and constructing clinical infrastructure to ensure safe and responsible access and treatment.
The company went public on the CSE this week, the first publicly-traded company focused on the safe supply ecosystem. The stock went live on October 3 2023, under the trading symbol “SPLY”.
See the full press release below and stay tuned to Microdose for more on this.
Safe Supply Streaming Co. Ltd. to Begins Trading on the CSE, October 3, 2023
Trading Symbol: SPLY
Toronto, Ontario–(Newsfile Corp. – October 3, 2023) – Safe Supply Streaming Co. Ltd. (CSE: SPLY) (“Safe Supply” or “Company“), the first company investing in and incubating companies at the forefront of the third wave of drug policy reform, is pleased to announce it will begin trading on the Canadian Securities Exchange (the “CSE“) today, October 3 2023, under the trading symbol “SPLY“.
“The burgeoning safe supply ecosystem is more than just a business; it’s a movement,” said Bill Panagiotakopoulos, CEO of Safe Supply Streaming Co. “A global shift is underway where governments, policymakers and societies are making the decision to accept and embrace all drugs, whether through de-scheduling, re-scheduling or legalization because existing policies simply haven’t worked. Our strategic positioning and our experienced leadership team, backed by a robust financial foothold, positions us to move quickly on initiatives that will have impact and build a promising future that is not only profitable but also sustainable and responsible.”
A Glimpse into the Future
Safe Supply’s listing on the CSE comes on the cusp of a transformative era in health and wellness, as global drug policy moves from prohibition to regulation and access. At the time of listing, the Company has a robust financial cash base, and a strategy that aligns its success with pivotal drug policy reform movements – from the rescheduling of MDMA and psilocybin in Australia to the innovative legal supply policy initiatives in Switzerland to the globally leading safe supply programs in British Columbia.
Led by an executive leadership team of pioneers from the cannabis and psychedelics industries, Safe Supply has built a business model and strategy that is expected to yield substantial growth and advancements as the third wave of drug policy reform progresses. This strategy positions Safe Supply as a resolute voice and champion in the sector, leveraging the leadership team’s expertise to be first mover in the emerging global opportunities in the safe supply ecosystem.
As of October 3, 2023, SPLY has 70,217,750 common shares outstanding.
About Safe Supply
With a mission to help bring a responsible end to the war on drugs, Safe Supply Streaming Co. Ltd. is investing in and incubating companies at the forefront of the third wave of drug policy reform. As jurisdictions around the world move to decriminalize, regulate and legalize drugs, Safe Supply is investing in the infrastructure necessary to support the transition. From developing the facilities to analyze, manufacture and distribute psychoactive compounds including the coca plant, to investing in the research and innovation to harness the potential, and minimize the harm, of these medicines, to constructing the clinical infrastructure to ensure safe and responsible access and treatment, Safe Supply is building a platform of tightly woven companies that will help save millions of lives and build a safer, healthier post-war on drugs worlds.
Learn more at www.safesupply.com and follow Safe Supply on LinkedIn, Twitter, and Instagram.
For Further Information:
Bill Panagiotakopoulos
Chief Executive Officer and Director
Safe Supply Streaming Co. Ltd.
www.safesupplystreaming.com
bill@safesupply.com
The post Safe Supply Streaming Begins Trading on the CSE appeared first on Microdose.
psilocybin regulation decriminalization research legalize legalization psychoactive psychedelics mdma-
Psychedelics1 week ago
Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry
-
Psilocybin1 week ago
California advances bill for psychedelics centers
-
Psilocybin5 days ago
Passover Perspectives: Psychedelics, Moses, and the Burning Bush
-
Psychedelics1 week ago
Revive Therapeutics Announces FDA Acceptance of Meeting Request for Long COVID Diagnostic Product
-
Psychedelics1 week ago
Psychedelics Can Offer More Than Therapy On Its Own
-
Psychedelics4 days ago
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
-
Psychedelics5 days ago
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
-
Psychedelics5 days ago
Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research